SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.

Andere Sprachen Suzhou Fushilai Pharmaceutical Co., Ltd.

Aktien

301258

CNE1000058W2

301258

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 05.06.2024			% 5 Tage	% 1. Jan.
27.75 ^CNY	-1.74%		-9.64%	-14.03%

05.06.	Suzhou Fushilai Pharmaceutical Co., Ltd. kündigt die Umsetzung des endgültigen Gewinnausschüttungsplans (A-Aktien) für 2023 an, zahlbar am 12. Juni 2024	CI
22.04.	Suzhou Fushilai Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Implementation of Final Profit Distribution Plan (A Shares) for 2023, Payable on 12 June 2024	05.06.
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22.04.
Tranche Update on Suzhou Fushilai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	01.04.
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	29.03.
Suzhou Fushilai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	06.02.
Suzhou Fushilai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	05.02.
Fushilai Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Suzhou Fushilai Pharmaceutical Co., Ltd.	18.12.
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19.10.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21.08.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for 2022, Payable on 08 June 2023	01.06.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022	10.05.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	18.04.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17.04.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17.04.23
Certain A Shares of Suzhou Fushilai Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-MAR-2023.	29.03.23
Fushilai Pharmaceutical to Apply for 375 Million Yuan Credit Lines This Year	16.03.23
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25.10.22
Suzhou Fushilai Pharmaceutical Co., Ltd. Approves Management Appointments	13.09.22
Suzhou Fushilai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22.08.22
Suzhou Fushilai Pharmaceutical Co., Ltd. Final Announces Cash Dividend on A Shares for 2021, Payable on June 8, 2022	01.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Suzhou Fushilai Pharmaceutical Co., Ltd.

Aktien

301258

CNE1000058W2

301258

Andere Sprachen

Filter